Polar Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-75,000
| Closed | -$2.48M | – | 300 |
|
|
2019
Q2 | $2.48M | Hold |
75,000
| – | – | 0.02% | 252 |
|
|
2019
Q1 | $2.63M | Buy |
+75,000
| New | +$2.63M | 0.02% | 236 |
|
|
2018
Q4 | – | Sell |
-75,000
| Closed | -$3.78M | – | 282 |
|
|
2018
Q3 | $3.78M | Sell |
75,000
-175,000
| -70% | -$8.81M | 0.03% | 224 |
|
|
2018
Q2 | $15K | Sell |
250,000
-25,000
| -9% | -$1.5K | 0.09% | 171 |
|
|
2018
Q1 | $12.6M | Buy |
275,000
+75,000
| +38% | +$3.44M | 0.13% | 166 |
|
|
2017
Q4 | $7.97M | Sell |
200,000
-138,956
| -41% | -$5.54M | 0.08% | 176 |
|
|
2017
Q3 | $13.6M | Buy |
338,956
+218,956
| +182% | +$8.76M | 0.15% | 144 |
|
|
2017
Q2 | $5.17M | Sell |
120,000
-405,000
| -77% | -$17.5M | 0.07% | 186 |
|
|
2017
Q1 | $16.4M | Buy |
525,000
+370,000
| +239% | +$11.6M | 0.25% | 120 |
|
|
2016
Q4 | $3.91M | Buy |
155,000
+77,500
| +100% | +$1.96M | 0.06% | 201 |
|
|
2016
Q3 | $1.92M | Sell |
77,500
-33,025
| -30% | -$817K | 0.03% | 218 |
|
|
2016
Q2 | $2.25M | Sell |
110,525
-11,561
| -9% | -$235K | 0.04% | 216 |
|
|
2016
Q1 | $1.86M | Buy |
122,086
+16,065
| +15% | +$245K | 0.04% | 214 |
|
|
2015
Q4 | $1.43M | Sell |
106,021
-48,922
| -32% | -$658K | 0.03% | 230 |
|
|
2015
Q3 | $2.17M | Buy |
154,943
+13,869
| +10% | +$195K | 0.04% | 216 |
|
|
2015
Q2 | $2.4M | Buy |
141,074
+29,401
| +26% | +$499K | 0.05% | 219 |
|
|
2015
Q1 | $1.35M | Buy |
111,673
+79,245
| +244% | +$958K | 0.03% | 243 |
|
|
2014
Q4 | $269K | Buy |
+32,428
| New | +$269K | 0.01% | 267 |
|